Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) has filed its Management Information Circular for an annual general and special meeting scheduled for October 30, 2026. The company is seeking shareholder approval for three key resolutions designed to streamline its capital structure and governance in preparation for a potential listing on a senior U.S. exchange.

The proposals include the creation of a new parent company, TopCo, through a share exchange; the subsequent redomicile of TopCo from British Columbia to Delaware; and an extension of the sunset date for the company’s multiple voting shares (MVS). Charles Bachtell, CEO of Cresco Labs, stated that these measures aim to lower administrative costs and complexity while positioning the firm for U.S. capital markets access.

Proposed structural changes

The board has unanimously recommended that shareholders vote in favor of each resolution. The specific measures under consideration are:

1. Share Exchange Resolution: This involves creating TopCo as the new publicly listed entity. Cresco Labs securities would be exchanged for TopCo securities on a one-for-one basis, leaving shareholders’ relative voting and economic rights unchanged. The board retains discretion to effect a reverse share split if necessary to meet U.S. exchange listing requirements.

2. Redomicile to Delaware: If approved, TopCo would move its domicile from British Columbia to Delaware. This step aligns the corporate structure with operational jurisdictions and makes it more familiar to U.S. investors. The resolution also provides for the adoption of a new long-term equity incentive plan tailored for a U.S.-domiciled issuer. The board may implement this change at any time on or before December 31, 2027.

3. MVS Sunset Extension: The proposal seeks to amend the terms of the MVS by extending the sunset date from the first anniversary to the third anniversary of a U.S. listing. This extension is intended to support strategic continuity during the redomicile and listing process, after which the multiple voting shares would convert automatically.

Meeting logistics and other agenda items

In addition to the special resolutions, shareholders will review financial statements for the years ended December 31, 2025 and December 31, 2024. Other annual business items include setting the number of directors at seven, electing directors, and reappointing Baker Tilly US, LLP as the independent auditor.

The meeting will be held via live audio webcast at 12:00 pm Central Daylight Time on Friday, October 30, 2026. Shareholders of record as of the close of business on September 15, 2026 are entitled to vote. Proxies must be received by 12:00 pm Central Daylight Time on Wednesday, October 28, 2026.

Regulatory context

The company emphasized that this announcement does not constitute an offer to sell securities or a solicitation of any vote in any jurisdiction where such action would contravene applicable law. The full text of the circular and related materials are available on SEDAR+ and EDGAR.

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) has appointed Edward Tilly to its Board of Directors, effective September 18, 2026. The appointment brings the Board size to eight directors.

Tilly will serve as an independent director and join the Audit Committee. He brings more than 35 years of experience in exchange operations, market structure, capital markets, and global regulatory engagement.

Executive Background

Tilly served as Chairman and CEO of CBOE Global Markets for a decade. During his tenure, he helped transform the company from a domestic options exchange into a diversified global market infrastructure operator. He oversaw the growth of its market capitalization from approximately US$2 billion to more than US$18 billion.

He led CBOE’s US$3.4 billion acquisition of BATS Global Markets and expanded the company’s operational footprint to six continents. From 2021 to 2023, he served as Chairman of the World Federation of Exchanges. He has held board seats at the Options Clearing Corporation and the National Stock Exchange.

Most recently, Tilly was CEO of Clear Street, a prime brokerage and financial infrastructure firm. He continues to serve on Clear Street’s Board of Directors.

Strategic Rationale

Tom Manning, Cresco Labs Chairman of the Board, highlighted Tilly’s expertise in public market infrastructure. Manning stated that as the federal landscape evolves and U.S. capital markets access opens to companies like Cresco Labs, Tilly’s perspective is critical for navigating strategic and financial opportunities.

Tilly commented that Cresco Labs has built a leading branded portfolio in U.S. cannabis and a retail platform that consistently outperforms its markets. He noted that this operating foundation positions the company well as access to U.S. capital markets broadens.

Company Overview

Cresco Labs aims to normalize and professionalize the cannabis industry through a consumer packaged goods approach to building national brands. The company operates Sunnyside dispensaries and distributes brands including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s, and Remedi.